EL7.AI पर प्रदान की गई जानकारी केवल शैक्षिक और सूचनात्मक उद्देश्यों के लिए है और यह वित्तीय सलाह नहीं है।
EL7.AI पर प्रदान की गई जानकारी केवल शैक्षिक और सूचनात्मक उद्देश्यों के लिए है और यह वित्तीय सलाह नहीं है।
NovaBay Pharmaceuticals has officially rebranded as Stablecoin Development Corporation, marking a complete strategic shift from healthcare to the digital asset sector. This transformation follows a substantial capital injection of $134 million from prominent investors, including Tether Investments and Framework Ventures. As part of its new focus, the company has acquired 2.06 billion SKY tokens and reported its initial staking rewards. The pivot highlights the company's commitment to stablecoin development and crypto asset management, backed by major industry players. Industry experts view this move as a significant fundamental change that signals a long-term commitment to the blockchain ecosystem. The rebranding and massive investment are expected to drive speculative interest and potentially increase the valuation of the company's stock and associated digital assets.
इस कंटेंट को एक्सेस करने के लिए मुफ्त साइन अप करें
मुफ्त अकाउंट बनाएं